Are research peptides legal in the UK?

This question gets a lot of confident answers from people selling the products, which is a reason to be careful about the answer. Here is the position as plainly as we can put it.

The short version

Compounds such as retatrutide, tirzepatide, BPC-157, TB-500 and GHK-Cu are not controlled drugs under the Misuse of Drugs Act. Buying them, selling them and holding them for laboratory research is lawful in the United Kingdom.

They are also not licensed medicines. Nothing here has a marketing authorisation from the MHRA, and that is where the constraint lives — not in possession, but in what may be said about them and what they may be sold for.

What the constraint actually is

The Human Medicines Regulations 2012 govern this. Two provisions do most of the work.

Regulation 279 prohibits advertising a medicinal product that has no marketing authorisation in force. Regulation 284 prohibits publishing an advertisement likely to lead to the use of a prescription-only medicine.

That second one matters more than it first appears. Tirzepatide and semaglutide are prescription-only medicines in the UK. So content that promotes them to the public engages regulation 284 whether or not the seller describes the product as research material, and regardless of what the label says.

Breach is a criminal matter enforced by the MHRA, not a platform policy question. The UK Advertising Codes run in parallel: CAP rule 12.12 prohibits advertising prescription-only medicines to the public, and the ASA has ruled that indirect references count — phrases along the lines of a weight-loss injection or a weight-loss pen, and images of injection pens, have all been held to breach it.

So where is the line?

It falls between describing a substance and promoting its use in a person.

Lawful: what the compound is, what it binds to, how it is made, how it is stored, what an independent laboratory measured in it, what the research literature examines.

Not lawful: presenting it as a treatment, describing how a person should use it, quantities and frequencies for personal use, before-and-after imagery, testimonials, or any claim about what it does in a body.

This is why you will not find a dosing guide on this site, and why the product pages describe receptors rather than results. It is not coyness. It is the difference between a research supplier and an unlicensed pharmacy, and it is the whole of our legal position.

Which compound sits in which regulatory state is a separate question from whether it can be sold, and it is set out compound by compound in FDA approved, MHRA licensed, or neither.

"Is selling peptides legal in the UK?"

Selling for research use is lawful. Selling them as medicines is not, and neither is advertising them that way.

In practice the sellers who get into difficulty are rarely caught out by what they stock. They are caught by their own marketing: a protocol page, a calculator, a results photograph, a claim about a condition. The stock was never the problem.

Our ten-point checklist sets out what to look for in a supplier, and the short version of it is that a seller who is relaxed about the advertising rules is unlikely to be rigorous about anything else.

"Are they legal to take?"

We are not going to answer that, and you should be wary of any seller who does.

Nothing sold here is authorised for use in a person. A supplier willing to tell you otherwise is either unaware of regulation 284 or unconcerned by it, and in both cases has told you something useful about how they operate. If you want an answer to a question about your own health, it belongs with a doctor and not with a shop.

Importing, and sport

Bringing research materials into the UK is a customs matter as well as a medicines one, and consignments do get stopped. We cover what that looks like in will UK customs seize peptides.

Separately, and often confused with the legal question: many of these compounds appear on the World Anti-Doping Agency prohibited list. That is a sporting-eligibility question rather than a criminal one, but for anyone subject to testing it is the more immediately relevant of the two.

What this means when you are choosing a supplier

The law here is not obscure and it is not new. Every seller in this market is subject to the same two regulations, and they respond to them very differently.

Read what a supplier publishes. If there are protocols, calculators, results photographs or claims about conditions, you are not looking at a research supplier — you are looking at a shop that has decided the rules are someone else's problem. What that tells you about their paperwork is the part worth paying attention to.